Stockreport

AZTR: Planning 2nd Site for ATR-12 Trial [Yahoo! Finance]

Azitra Inc  (AZTR) 
PDF Azitra, Inc. (NYSE:AZTR) reported third quarter results in mid-November highlighting its $10 million raise back in July, dosing of the first patient in the Netherton sy [Read more]